Xi Jin,Jiang-Shan Lian,Jian-Hua Hu,Jianguo Gao,Lin Zheng,Yi-Min Zhang,Shao-Rui Hao,Hong-Yu Jia,Huan Cai,Xiao-Li Zhang,Guo-Dong Yu,Kai-Jin Xu,Xiao-Yan Wang,Jue-Qing Gu,Shan-Yan Zhang,Chan-Yuan Ye,Ci-Liang Jin,Ying-Feng Lu,Xia Yu,Xiao-Peng Yu,Jian-Rong Huang,Kang-Li Xu,Qin Ni,Cheng-Bo Yu,Biao Zhu,Yong-Tao Li,Jun Liu,Hong Zhao,Xuan Zhang,Liang Yu,Yong-Zheng Guo,Jun-Wei Su,Jing-Jing Tao,Guan-Jing Lang,Xiao-Xin Wu,Wen-Rui Wu,Ting-Ting Qv,Dai-Rong Xiang,Ping Yi,Ding Shi,Yanfei Chen,Yue Ren,Yun-Qing Qiu,Lan-Juan Li,Jifang Sheng,Yida Yang

Abstract:ObjectiveThe SARS-CoV-2-infected disease (COVID-19) outbreak is a major threat to human beings. Previous studies mainly focused on Wuhan and typical symptoms. We analysed 74 confirmed COVID-19 cases with GI symptoms in the Zhejiang province to determine epidemiological, clinical and virological characteristics.DesignCOVID-19 hospital patients were admitted in the Zhejiang province from 17 January 2020 to 8 February 2020. Epidemiological, demographic, clinical, laboratory, management and outcome data of patients with GI symptoms were analysed using multivariate analysis for risk of severe/critical type. Bioinformatics were used to analyse features of SARS-CoV-2 from Zhejiang province.ResultsAmong enrolled 651 patients, 74 (11.4%) presented with at least one GI symptom (nausea, vomiting or diarrhoea), average age of 46.14 years, 4-day incubation period and 10.8% had pre-existing liver disease. Of patients with COVID-19 with GI symptoms, 17 (22.97%) and 23 (31.08%) had severe/critical types and family clustering, respectively, significantly higher than those without GI symptoms, 47 (8.14%) and 118 (20.45%). Of patients with COVID-19 with GI symptoms, 29 (39.19%), 23 (31.08%), 8 (10.81%) and 16 (21.62%) had significantly higher rates of fever >38.5°C, fatigue, shortness of breath and headache, respectively. Low-dose glucocorticoids and antibiotics were administered to 14.86% and 41.89% of patients, respectively. Sputum production and increased lactate dehydrogenase/glucose levels were risk factors for severe/critical type. Bioinformatics showed sequence mutation of SARS-CoV-2 with m6A methylation and changed binding capacity with ACE2.ConclusionWe report COVID-19 cases with GI symptoms with novel features outside Wuhan. Attention to patients with COVID-19 with non-classic symptoms should increase to protect health providers.

Epidemiological, Clinical and Virological Characteristics of 74 Cases of Coronavirus-Infected Disease 2019 (COVID-19) with Gastrointestinal Symptoms